Companies: 10,795·Total market cap: $144.5T
Autolus Therapeutics plc

Autolus Therapeutics plc

AUTLNASDAQHealthcare● Active
$1.46
$-0.07(-4.58%)
Market Cap$388569170
P/E Ratio—
52W High$2.7
52W Low$1.175
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Autolus Therapeutics plc (AUTL) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001730463 · AUTL · NASDAQ · as of Jun 8, 2026

Filing snapshot

313
Total Filings
SCHEDULE 13G/A
Latest Form
2026-05-15
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001730463 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-27
Fiscal Year End
Mar 27, 2026
Accession No.
0001730463-26-000038
Primary Document
autl-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001730463 · Accession 0001730463-26-000038

Latest Key Filings

6-KQuarterly Report
6-K
2023-11-02
View 6-K on SEC
8-KCurrent Report
8-K
2026-05-14Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-14
View
EFFECTEFFECT
EFFECT
2026-05-05
View
EFFECTEFFECT
EFFECT
2026-05-05
View
CORRESPCORRESP
CORRESP
2026-05-01
View
CORRESPCORRESP
CORRESP
2026-05-01
View
8-KCurrent Report
8-K
2026-04-29
View
8-KCurrent Report
8-K
2026-04-16
View
UPLOADUPLOAD
UPLOAD
2026-04-15
View
UPLOADUPLOAD
UPLOAD
2026-04-15
View
DEL AMDEL AM
DEL AM
2026-04-15
View
DEL AMDEL AM
DEL AM
2026-04-15
View
S-3Shelf Registration
S-3
2026-04-13
View
Showing 1–15 of 312 filingsForm 4 / 144 hidden· 313 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001730463  |  Exchange: NASDAQ · Healthcare

Autolus Therapeutics plc (NASDAQ: AUTL) has submitted 313 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001730463, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Autolus Therapeutics plc's most comprehensive regulatory disclosure. The most recent Autolus Therapeutics plc 10-K was filed on 2026-03-27 for fiscal year ending 2026. Historical AUTL 10-K annual reports are available from 2018 through 2026.

Investors researching Autolus Therapeutics plc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
RAPT SEC Filings →LBRX SEC Filings →ANNX SEC Filings →SLDB SEC Filings →AURA SEC Filings →NMRA SEC Filings →RCKT SEC Filings →BNTC SEC Filings →
→ AUTL Financials→ AUTL Earnings→ AUTL Insider Trades

Frequently Asked Questions

AUTL SEC Filings · 8 questions

Autolus Therapeutics plc (AUTL) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 313 filings and access original documents at no cost. Autolus Therapeutics plc's CIK is 0001730463.

AUTL SEC filingsAutolus Therapeutics plc SEC documentsfind AUTL 10-K